Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3811401 | 0.87 | CCNE2 (0.32) | — | |
| SCHEMBL3811681 | 0.86 | BACE1 (0.35) | RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL3611287 | 0.86 | HTR7 (0.35) | L3MBTL1MAPK1LMNATDP1HTR7 | |
| SCHEMBL626368 | 0.83 | PDK2 (0.38) | — | |
| SCHEMBL3681805 | 0.81 | NUDT1 (0.32) | — | |
| SCHEMBL3811684 | 0.81 | HSD11B1 (0.36) | ALDH1A1 | |
| SCHEMBL3769171 | 0.81 | GRM4 (0.37) | L3MBTL1LMNAGAARAB9ATP53 | |
| SCHEMBL618897 | 0.79 | — | — | |
| SCHEMBL3806063 | 0.76 | BACE1 (0.34) | MAPK1ALDH1A1 | |
| SCHEMBL3683551 | 0.74 | NPC1 (0.31) | LMNAALDH1A1KDM4ESMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910427-B1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS | SK INNOVATION CO LTD (KR) | 2015-05-13 | — | — | EP | disclosed |
| US-7833926-B2 | Arylphenoxy catalyst system for producing ethylene homopolymer or copolymers of ethylene and α-olefins | SK ENERGY CO., LTD. (KR) | 2010-11-16 | — | — | US | disclosed |
| US-20090326175-A1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS | SK ENERGY CO., LTD. (KR) | 2009-12-31 | — | — | US | disclosed |
| US-7589042-B2 | Arylphenoxy catalyst system for producing ethylene homopolymer or copolymers of ethylene and α-olefins | SK CORPORATION (KR) | 2009-09-15 | — | — | US | disclosed |
| EP-1910427-A1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS | SK Energy Co., Ltd. (KR) | 2008-04-16 | — | — | EP | disclosed |
| US-20070135297-A1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS | SK CORPORATION (KR) | 2007-06-14 | — | — | US | disclosed |
| WO-2007040294-A1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS | SK ENERGY CO., LTD. (KR) | 2007-04-12 | — | — | WO | disclosed |
| US-20070004586-A1 | Arylphenoxy catalyst system for producing ethylene homopolymer or copolymers of ethylene and alpha-olefins | SK CORPORATION (KR) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326175-A1 | ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS | ESR1, ERO1A, PPOX | L3MBTL1 2232/4885MAPK1 1918/4885LMNA 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.